-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FQ9BMFLLAj1rxDh4/xRu2um+fQg/xz4zFY11WShQSGeypTvbgZ6g16ACYG3wlEbM RpKJYrMf76VHaSDi/KPfaw== 0000950172-01-501105.txt : 20020410 0000950172-01-501105.hdr.sgml : 20020410 ACCESSION NUMBER: 0000950172-01-501105 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20011109 GROUP MEMBERS: CLOVERLEAF HOLDINGS LIMITED GROUP MEMBERS: GENELINK HOLDINGS LIMITED GROUP MEMBERS: RADDISON TRUSTEE LIMITED SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: SEQUENOM INC CENTRAL INDEX KEY: 0001076481 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 770365889 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-60383 FILM NUMBER: 1780197 BUSINESS ADDRESS: STREET 1: 3595 JOHN HOPKINS CT CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8582029000 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: FITZGERALD MICHAEL CENTRAL INDEX KEY: 0001160360 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: LE REGINA STREET 2: 13-15 BOULEVARD DES MOULINS CITY: MC 98000 MONACO STATE: O9 ZIP: 00000 BUSINESS PHONE: 01137793256719 MAIL ADDRESS: STREET 1: LE REGINA STREET 2: 13-15 BOULEVARD DES MOULINS CITY: MC 98000 MONACO STATE: O9 ZIP: 00000 SC 13D/A 1 s563872.txt SC 13D/A #1 As filed with the Securities and Exchange Commission on November 9, 2001 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2(a) (Amendment No. 1) SEQUENOM, INC. ----------------------------------------------------------------------------- (Name of Issuer) COMMON STOCK, PAR VALUE $.001 PER SHARE ----------------------------------------------------------------------------- (Title of Class and Securities) 817337 10 8 ----------------------------------------------------------------------------- (CUSIP Number) Michael Fitzgerald Raddison Trustee Limited "Le Regina" c/o FM Trust, S.A. 13-15 boulevard des Moulins Rue du Pommier 12 MC 98000 Monaco 2000 Neuchatel, Switzerland Copy to: Martha McGarry, Esq. Skadden, Arps, Slate, Meagher & Flom LLP Four Times Square New York, NY 10036 (212) 735-3000 ----------------------------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) October 1, 2001 ----------------------------------------------------------------------------- (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a Statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(b)(3) or (4), check the following [ ] Note: Six copies of this Statement, including all exhibits, should be filed with the Commission. See Rule 13d-1(a) for other parties to whom copies are to be sent. CUSIP No. 381197 10 2 ------------------------------------------------------------------- 1. NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (entities only) Michael Fitzgerald ------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP: (a) ( ) (b) (X) ------------------------------------------------------------------- 3. SEC USE ONLY ------------------------------------------------------------------- 4. SOURCE OF FUNDS 00 ------------------------------------------------------------------- 5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) ( ) ------------------------------------------------------------------- 6. CITIZENSHIP OR PLACE OF ORGANIZATION British ------------------------------------------------------------------- 7. SOLE VOTING POWER NUMBER OF 596,140(1) SHARES ------------------------------------- BENEFICIALLY 8. SHARED VOTING POWER OWNED BY 0 EACH ------------------------------------- REPORTING 9. SOLE DISPOSITIVE POWER PERSON 596,140(1) WITH ------------------------------------- 10. SHARED DISPOSITIVE POWER 0 ------------------------------------------------------------------- 11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 596,140 ------------------------------------------------------------------- 12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN SHARES ( ) ------------------------------------------------------------------- 13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11 1.6% ------------------------------------------------------------------- 14. TYPE OF REPORTING PERSON IN ------------------------------------------------------------------- (1) Mr. Fitzgerald holds options to purchase 107,400 shares exercisable within 60 days after the date of this Statement. Mr. Fitzgerald, Raddison Trustee Limited ("Raddison") and Cloverleaf Holdings Limited ("Cloverleaf") entered into a Termination Agreement, dated October 1, 2001, which provided for the termination of the Advisor Agreement, dated July 3, 1995, by and among such parties. Pursuant to the terms of the Termination Agreement, Mr. Fitzgerald received Raddison's entire interest in Cloverleaf, thereby becoming the beneficial owner of 488,740 shares held by Cloverleaf. Mr. Fitzgerald disclaims any beneficial ownership of shares owned by Raddison or Genelink Holdings Limited. CUSIP No. 381197 10 2 ------------------------------------------------------------------- 1. NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (entities only) Raddison Trustee Limited ------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP: (a) ( ) (b) (X) ------------------------------------------------------------------- 3. SEC USE ONLY ------------------------------------------------------------------- 4. SOURCE OF FUNDS 00 ------------------------------------------------------------------- 5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) ( ) ------------------------------------------------------------------- 6. CITIZENSHIP OR PLACE OF ORGANIZATION Cook Islands ------------------------------------------------------------------- 7. SOLE VOTING POWER NUMBER OF 3,490,972 (1) SHARES ------------------------------------- BENEFICIALLY 8. SHARED VOTING POWER OWNED BY - 0 - EACH ------------------------------------- REPORTING 9. SOLE DISPOSITIVE POWER PERSON 3,490,972 (1) WITH ------------------------------------- 10. SHARED DISPOSITIVE POWER - 0 - ------------------------------------------------------------------- 11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,490,972 (1) ------------------------------------------------------------------- 12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN SHARES ( ) ------------------------------------------------------------------- 13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11 9.4% ------------------------------------------------------------------- 14. TYPE OF REPORTING PERSON CO ------------------------------------------------------------------- (1) Raddison Trustee Limited, which is the sole stockholder of Genelink Holdings Limited, may be deemed to be the beneficial owner of 3,490,972 shares held by Genelink Holdings Limited. The reporting person disclaims beneficial ownership of such shares. CUSIP No. 381197 10 2 ------------------------------------------------------------------- 1. NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (entities only) Cloverleaf Holdings Limited ------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP: (a) ( ) (b) (X) ------------------------------------------------------------------- 3. SEC USE ONLY ------------------------------------------------------------------- 4. SOURCE OF FUNDS 00 ------------------------------------------------------------------- 5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) ( ) ------------------------------------------------------------------- 6. CITIZENSHIP OR PLACE OF ORGANIZATION British Virgin Islands ------------------------------------------------------------------- 7. SOLE VOTING POWER NUMBER OF 488,740 SHARES ------------------------------------- BENEFICIALLY 8. SHARED VOTING POWER OWNED BY - 0 - EACH ------------------------------------- REPORTING 9. SOLE DISPOSITIVE POWER PERSON 488,740 WITH ------------------------------------- 10. SHARED DISPOSITIVE POWER - 0- ------------------------------------------------------------------- 11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 488,740 ------------------------------------------------------------------- 12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN SHARES ( ) ------------------------------------------------------------------- 13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11 1.3% ------------------------------------------------------------------- 14. TYPE OF REPORTING PERSON CO ------------------------------------------------------------------- CUSIP No. 381197 10 2 ------------------------------------------------------------------- 1. NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (entities only) Genelink Holdings Limited ------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP: (a) ( ) (b) (X) ------------------------------------------------------------------- 3. SEC USE ONLY ------------------------------------------------------------------- 4. SOURCE OF FUNDS 00 ------------------------------------------------------------------- 5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) ( ) ------------------------------------------------------------------- 6. CITIZENSHIP OR PLACE OF ORGANIZATION British Virgin Islands ------------------------------------------------------------------- 7. SOLE VOTING POWER NUMBER OF 3,490,972 SHARES ------------------------------------- BENEFICIALLY 8. SHARED VOTING POWER OWNED BY - 0 - EACH ------------------------------------- REPORTING 9. SOLE DISPOSITIVE POWER PERSON 3,490,972 WITH ------------------------------------- 10. SHARED DISPOSITIVE POWER - 0- ------------------------------------------------------------------- 11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,490,972 ------------------------------------------------------------------- 12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN SHARES ( ) ------------------------------------------------------------------- 13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11 9.4% ------------------------------------------------------------------- 14. TYPE OF REPORTING PERSON CO ------------------------------------------------------------------- This Amendment No. 1 to Schedule 13D (this "Amendment") is being filed pursuant to Rule 13d-2(a) of the Rules and Regulations under the Securities Exchange Act of 1934, as amended (the "Act"), by (i) Michael Fitzgerald, an individual, (ii) Raddison Trustee Limited ("Raddison"), a company organized under the laws of the Cook Islands, (iii) Genelink Holdings Limited ("Genelink"), a company organized under the laws of the British Virgin Islands, and (iv) Cloverleaf Holdings Limited ("Cloverleaf"), a company organized under the laws of the British Virgin Islands, with respect to the common stock, par value $.001 per share, of Sequenom, Inc., a Delaware corporation (each of the individuals or entities listed under (i) through (iv), a "Reporting Person"). This Amendment amends the Schedule 13D filed by Mr. Fitzgerald, Raddison, Genelink and Cloverleaf on October 2, 2001. The Schedule 13D previously filed is hereby amended by the addition of the following information: Item 1. Security and Issuer. The title of the class of equity securities to which this Statement on Schedule 13D (this "Statement") relates is the common stock, par value $.001 per share (the "Common Stock"), of Sequenom, Inc., a Delaware corporation (the "Company"). The principal executive offices of the Company are located at 3595 John Hopkins Court, San Diego, CA 92121. Item 2. Identity and Background. This Statement is being filed by: (i) Mr. Fitzgerald, (ii) Raddison, (iii) Cloverleaf and (iv) Genelink, which is presently wholly owned by Mr. Fitzgerald. The name, business address, present principal occupation and citizenship of each executive officer and director of Raddison, Cloverleaf and Genelink are set forth in Exhibit A to this Statement and is specifically incorporated herein by reference. During the last five years, none of the Reporting Persons nor, to the best of their knowledge, any of their directors or executive officers has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors), nor has any of them been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction resulting in a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. Item 3. Source and Amount of Funds or Other Consideration. Mr. Fitzgerald, Raddison and Cloverleaf entered into a Termination Agreement, dated October 1, 2001, which provided for the termination of the Advisor Agreement, dated July 3, 1995, by and among such parties. Pursuant to the terms of the Termination Agreement, Mr. Fitzgerald received Raddison's entire interest in Cloverleaf, thereby becoming the beneficial owner of 488,740 shares of Common Stock held by Cloverleaf. Item 4. Purpose of the Transaction. The information set forth in Item 3 of this Statement is incorporated herein by reference. Item 5. Interest In Securities Of The Issuer As of September 20, 2001, based in part upon information provided by the Company, there were 37,316,558 outstanding shares of Common Stock. The filing of this Statement shall not be construed as an admission that any of the Reporting Persons is, for purposes of Section 13(d) or 13(g) of the Exchange Act, the beneficial owner of any securities held by any other person. Set forth below is certain information with respect to the beneficial ownership of the Reporting Persons. Michael Fitzgerald (a) Mr. Fitzgerald holds options to purchase 107,400 shares exercisable within 60 days after the date of this Statement. Mr. Fitzgerald is the sole owner of Cloverleaf. Cloverleaf owns 488,740 shares of Common Stock. The shares of Common Stock underlying the options and all of the shares of Common Stock owned by Cloverleaf represent 1.6% of the oustanding shares of Common Stock. (b) Mr. Fitzgerald has sole voting power and sole investment power with respect to all of the shares of Common Stock underlying the options and all of the shares of Common Stock owned by Cloverleaf referred to in paragraph (a) above. (c) Except as set forth in Item 3 of this Statement (which information is incorporated herein by reference), no transactions in the Common Stock (other than as described in Item 3 of this Statement) were effected by Mr. Fitzgerald in the past 60 days. (d) Except as set forth above in this Item 5, no other person is known to have the right to receive or the power to direct the receipt of dividends from or the proceeds from the sale of the shares. (e) Mr. Fitzgerald, Raddison and Cloverleaf entered into a Termination Agreement, dated October 1, 2001, which provided for the termination of the Advisor Agreement, dated July 3, 1995, by and among such parties. Pursuant to the terms of the Advisor Agreement, the relationship Mr. Fitzgerald had with Raddison and Genelink was terminated and, as a result, Mr. Fitzgerald ceased to be the beneficial owner of the 3,490,972 shares of Common Stock held by Genelink. Mr. Fitzgerald disclaimed any such beneficial ownership prior to October 1, 2001. Raddison Trustee Limited (a) Raddison may be deemed to be the beneficial owner of 3,490,972 shares held by Genelink (representing 9.4% of the outstanding shares of Common Stock). The Reporting Person disclaims beneficial ownership of such shares. (b) Raddison may be deemed to have sole voting power and sole investment power with respect to all of the shares of Common Stock referred to in paragraph (a) above. (c) Except as set forth in Item 3 of this Statement (which information is incorporated herein by reference), no transactions in the Common Stock (other than as described in Item 3 of this Statement) were effected by Raddison in the past 60 days. (d) Except as set forth above in this Item 5, no other person is known to have the right to receive or the power to direct the receipt of dividends from or the proceeds from the sale of the shares. Item 6. Contracts, Arrangements, Understandings or Relationships w ith Respect to Securities of the Issuer. The information contained in Items 3, 4 and 5 of this Statement is incorporated herein by reference. Item 7. Material to be Filed as Exhibits. Exhibit A Schedule of certain information with respect to Raddison, Cloverleaf and Genelink. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this Statement is true, complete and correct. Date: November 9, 2001 /s/ Michael Fitzgerald -------------------------------------- Name: Michael Fitzgerald RADDISON TRUSTEE LIMITED By: /s/ Denise Zwahlen ----------------------------------- Name: Denise Zwahlen Title: Director CLOVERLEAF HOLDINGS LIMITED By: /s/ Rita Euziere ---------------------------------- Name: Rita Euziere Title: Director GENELINK HOLDINGS LIMITED By: /s/ Nicholas Karpusheff ----------------------------------- Name: Nicholas Karpusheff Title: Director Exhibit A DIRECTORS AND EXECUTIVE OFFICERS Raddison Trustee Limited - ------------------------ Director: Ms. Linda Gygax Address: FM Trust S.A., Rue du Pommier 12, 2000 Neuchatel, Switzerland Occupation: Executive General Manager, FM Trust S.A. Citizenship: Swiss Director: Ms. Denise Zwahlen Address: FM Trust S.A., Rue du Pommier 12, 2000 Neuchatel, Switzerland Occupation: Executive Office Manager, FM Trust S.A. Citizenship: Swiss Cloverleaf Holdings Limited - --------------------------- Director: Michael Fitzgerald Address: "Le Regina", 13-15 boulevard des Moulins, MC 98000 Monaco Occupation: Financial Consultant Citizenship: British Director: Rita Euziere Address: "Le Bermuda", 49 avenue Hector Otto, MC 98000 Monaco Occupation: Executive Legal and Corporate Assistant Citizenship: Irish Genelink Holdings Limited - ------------------------- Director: Nicholas Karpusheff Address: 19 boulevard de Suisse, MC 98000 Monaco Occupation: Accountant Citizenship: British Director: Houwina Dijkstra Address: Rue Saint Joseph Ilot Rey Serrurier, 06300 Nice, France Occupation: Office Manager Citizenship: Dutch -----END PRIVACY-ENHANCED MESSAGE-----